Becker's Spine Review

Becker's May 2020 Spine Review

Issue link: https://beckershealthcare.uberflip.com/i/1242960

Contents of this Issue

Navigation

Page 44 of 47

45 HEALTHCARE NEWS How many hospitals does each state have? By Laura Dyrda Texas has 407 hospitals, the most in the coun- try, according to CMS. All total, there were 4,749 acute care hospitals, critical access hospitals and children's hospi- tals in the U.S. as of Dec. 19, 2016, according to CMS' Hospital Compare list of all hospitals that have been registered with Medicare. Nineteen states have more than 100 hospitals. Here is the breakdown of hospitals per state. Texas: 407 California: 341 Florida: 186 Illinois: 180 New York: 172 Pennsylvania: 170 Ohio: 168 Kansas: 137 Georgia: 134 Michigan: 131 Minnesota: 131 Wisconsin: 126 Oklahoma: 123 Louisiana: 122 Indiana: 120 Iowa: 116 Missouri: 114 Tennessee: 109 North Carolina: 106 Mississippi: 96 Kentucky: 94 Washington: 91 Nebraska: 90 Alabama: 89 Virginia: 87 Arizona: 81 Colorado: 78 Arkansas: 74 New Jersey: 66 Massachusetts: 64 Montana: 61 Oregon: 60 South Carolina: 60 South Dakota: 60 Maryland: 49 West Virginia: 49 Utah: 46 North Dakota: 44 Idaho: 41 New Mexico: 41 Maine: 33 Nevada: 33 Connecticut: 31 Wyoming: 27 New Hampshire: 26 Hawaii: 23 Alaska: 22 Vermont: 14 Rhode Island: 11 Washington, D.C.: 8 Delaware: 7 n Medacta's 2019 revenue jumped 13.9%, but 2020 uncertain due to COVID-19: 5 key points By Laura Dyrda Medacta reported a sales increase in 2019 and a strong start of the year before the coronavirus pandemic hit. Five things to know: 1. Medacta reported revenue at $335.4 million, an in- crease of 13.9 percent over the same period last year. The company reported its hip line sales were up 5.2 per- cent and knee product line sales were up 13.2 percent. The spine product line revenue was up 23.4 percent year over year. 2. The company reported gross profit of $241.5 million in 2019, a 9.6 percent increase. 3. European sales were up 7.9 percent, and sales in North America grew 13.2 percent. Medacta reported the U.S. re- mains one of the key focus areas for 2020. 4. For 2020, the company declined to release a yearly outlook due to the coronavirus pandemic. The company has seen a reduction in elective surgeries worldwide and reduced marketing, medical education and other events due to travel restrictions. However, the company does ex- pect that orthopedic patients will generate a waiting list in some companies and it could see a recovery later this year or in 2021. 5. Medacta's board of directors proposed not distributing dividends for the 2019 financial year to protect cash flow amid the pandemic. n

Articles in this issue

view archives of Becker's Spine Review - Becker's May 2020 Spine Review